Mettler-Toledo International has Most Pricing Power in Analytical Instruments Industry, RBC Says

MT Newswires Live

09/01

Mettler-Toledo International (MTD) has the most pricing power in the analytical instruments industry, RBC Capital Markets said in a Tuesday note.

A feature that differentiates Mettler-Toledo from some of its peers is its exposure to industries outside of biomedical research and production, which comprise about 45% of its sales, lower than the 60% average among peers, RBC said.

RBC said that while the mix difference didn't drive relative outperformance for Mettler-Toledo's stock during the 2024-2025 period of weakness in biomedical research, this trend now appears to be reversing.

Macro conditions support an acceleration in the company's organic sales growth in H2 and beyond, but this boost does not guarantee upside relative to companies more exposed to any biomedical research inflection, the firm said.

RBC initiated coverage on the stock with a sector perform rating and a $1,515 price target.

Price: 1387.40, Change: -17.74, Percent Change: -1.26

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2664850331"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2664850331\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2664850331?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-01 23:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2664850331","market":"nz","top_or_hot":-1,"title":"Mettler-Toledo International has Most Pricing Power in Analytical Instruments Industry, RBC Says","media":"MT Newswires Live","content":"<html><body><p> Mettler-Toledo International (MTD) has the most pricing power in the analytical instruments industry, RBC Capital Markets said in a Tuesday note.</p><p>A feature that differentiates Mettler-Toledo from some of its peers is its exposure to industries outside of biomedical research and production, which comprise about 45% of its sales, lower than the 60% average among peers, RBC said.</p><p>RBC said that while the mix difference didn't drive relative outperformance for Mettler-Toledo's stock during the 2024-2025 period of weakness in biomedical research, this trend now appears to be reversing.</p><p>Macro conditions support an acceleration in the company's organic sales growth in H2 and beyond, but this boost does not guarantee upside relative to companies more exposed to any biomedical research inflection, the firm said.</p><p>RBC initiated coverage on the stock with a sector perform rating and a $1,515 price target.</p><p>Price: 1387.40, Change: -17.74, Percent Change: -1.26</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mettler-Toledo International has Most Pricing Power in Analytical Instruments Industry, RBC Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMettler-Toledo International has Most Pricing Power in Analytical Instruments Industry, RBC Says\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2026-09-01 23:10</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Mettler-Toledo International (MTD) has the most pricing power in the analytical instruments industry, RBC Capital Markets said in a Tuesday note.</p><p>A feature that differentiates Mettler-Toledo from some of its peers is its exposure to industries outside of biomedical research and production, which comprise about 45% of its sales, lower than the 60% average among peers, RBC said.</p><p>RBC said that while the mix difference didn't drive relative outperformance for Mettler-Toledo's stock during the 2024-2025 period of weakness in biomedical research, this trend now appears to be reversing.</p><p>Macro conditions support an acceleration in the company's organic sales growth in H2 and beyond, but this boost does not guarantee upside relative to companies more exposed to any biomedical research inflection, the firm said.</p><p>RBC initiated coverage on the stock with a sector perform rating and a $1,515 price target.</p><p>Price: 1387.40, Change: -17.74, Percent Change: -1.26</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4533","symbol_name":"AQR資本管理(全球第二大對沖基金)","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2664850331","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2664850331","pubTimestamp":1788275415,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Mettler-Toledo International  has the most pricing power in the analytical instruments industry, RBC Capital Markets said in a Tuesday note.A feature that differentiates Mettler-Toledo from some of its peers is its exposure to industries outside of biomedical research and production, which comprise about 45% of its sales, lower than the 60% average among peers, RBC said.RBC said that while the mix difference didn't drive relative outperformance for Mettler-Toledo's stock during the 2024-2025 period of weakness in biomedical research, this trend now appears to be reversing.Macro conditions support an acceleration in the company's organic sales growth in H2 and beyond, but this boost does not guarantee upside relative to companies more exposed to any biomedical research inflection, the firm said.RBC initiated coverage on the stock with a sector perform rating and a $1,515 price target.Price: 1387.40, Change: -17.74, Percent Change: -1.26","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4121":"生命科学工具和服务","LU2211817866.USD":"Allianz Food Security AT Acc USD","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","IE00BFXG0V08.USD":"BNY MELLON GLOBAL LEADERS \"B\" (USD) ACC","IE00BYQQ9H92.USD":"BNY MELLON GLOBAL LEADERS \"A\" (USD) ACC","LU0347712357.USD":"BNP PARIBAS GLOBAL ENVIRONMENT \"C\" (USD) ACC","BK4588":"碎股","BK4585":"ETF&股票定投概念","IE00B5TLWC47.USD":"BNY MELLON LONG-TERM GLOBAL EQUITY \"B\" (USD) ACC","BK4567":"ESG概念","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","LU2413666426.HKD":"BNP PARIBAS GLOBAL ENVIRONMENT \"C\" (HKD) ACC","LU1721428933.USD":"法巴全球经典环境基金RH MD Dis","MTD":"梅特勒-托利多","BK4548":"巴美列捷福持仓","LU2413666699.HKD":"BNP PARIBAS GLOBAL ENVIRONMENT \"CRH\" (HKDHDG) INC"},"translate_title":"加拿大皇家银行表示，梅特勒-托利多国际公司在分析仪器行业拥有最大的定价权","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MTD":1.5},"content_text":"Mettler-Toledo International (MTD) has the most pricing power in the analytical instruments industry, RBC Capital Markets said in a Tuesday note.A feature that differentiates Mettler-Toledo from some of its peers is its exposure to industries outside of biomedical research and production, which comprise about 45% of its sales, lower than the 60% average among peers, RBC said.RBC said that while the mix difference didn't drive relative outperformance for Mettler-Toledo's stock during the 2024-2025 period of weakness in biomedical research, this trend now appears to be reversing.Macro conditions support an acceleration in the company's organic sales growth in H2 and beyond, but this boost does not guarantee upside relative to companies more exposed to any biomedical research inflection, the firm said.RBC initiated coverage on the stock with a sector perform rating and a $1,515 price target.Price: 1387.40, Change: -17.74, Percent Change: -1.26","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}